Federal health officials have proposed new rules that would require much faster decisions on prescription drug prior ...
The FDA has granted fast track designation to OPN-6602, an investigational oral dual inhibitor of EP300 and CREB-binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results